Skip to content
All Updates
- Rapid Alert: Recall of Contaminated Liquid PreparationsSeptember 11, 2024
- Minutes of 298th Meeting of Central Licensing Board held on 26th July, 2024September 10, 2024
- Rapid Alert: Recall of Contaminated Liquid PreparationsSeptember 6, 2024
- Rapid Alert: Crackdown Against Spurious/Falsified Drug ProductsSeptember 6, 2024
- Recall Alert: Drug Products; Recall of 11 Substandard Batches from the MarketSeptember 6, 2024
- Minutes of 339th meeting of Registration Board held on 6th – 8th August, 2024September 3, 2024
- S.R.O. 1324(l)12024 – Revision of Regulatory Fee NotificationSeptember 2, 2024
- Orientation Session For Pharmaceutical Manufacturers on PIC/s GMP GuidelinesAugust 23, 2024
- Rapid Alert: Falsified Propylene Glycol in Supply Chain MarketAugust 22, 2024
- DRAP Switched Over to Pakistan Single Window (PSW) for Regulatory Controls on Crossborder Trade at Karachi Custom StationsAugust 20, 2024
- Minutes of 50th Meeting of Clinical Studies CommitteeAugust 13, 2024
- Stakeholders Comments are invited on Draft Guidelines On Submission of Expenditure Details Under the Ethical Marketing To Healthcare Professionals Rules, 2021August 9, 2024
- Revocation of Form-6 (provisional certificate for enlistment as manufacturer /importer & Form-7 (provisional certificate for enlistment of products)August 8, 2024
- DRAP Pharmacovigilance Newsletter-August 2024July 31, 2024
- Registration Board directed manufacturers to follow USP Monograph for Ciprofloxacin Oral SuspensionJuly 25, 2024
- Minutes of 49th Meeting of Clinical Studies CommitteeJuly 24, 2024
- Webinar on Building Effective Medicine Pricing Policies for Low- and Middle-Income CountriesJuly 23, 2024
- Minutes of 337th meeting of Registration Board held on 28th June, 2024July 23, 2024
- Minutes of 338th meeting of Registration Board held on 4th July, 2024July 9, 2024
- Bioequivalence and Bioavailability of Drug ProductsJuly 8, 2024
- Minutes of 336th meeting of Registration Board held on 04-06 June, 2024July 8, 2024
- DRAP Finalized Guidelines on Standards for Establishment of Hospital Pharmacies June 25, 2024
- Recall Alert: Drug Products; Recall of 12 Substandard Batches from the MarketJune 14, 2024
- Rapid Alert: Crackdown Against Spurious/falsified Drug ProductsJune 14, 2024
- Decisions of 68th Meeting of Medical Device Board (Deficiency letter for Medical Devices Applications)June 13, 2024
- Series of Training on National Pharmacovigilance System for Registration holders (Manufacturers and Importers)June 12, 2024
- Rapid Alert: Busting of Illegal Manufacturing Site producing Unregistered Boostin (RBST) InjectionsJune 10, 2024
- Recall Alert: Drug Product; Water for Injection (Batch 989) by Zafa Pharmaceutical Pvt Ltd, KarachiJune 10, 2024
- Tender notice for supply of Fourier Transform Infrared Spectrophotometer (FTIR) to CDL Karachi)May 31, 2024
- Voluntary Recall Alert: Drug Product; Cadlec 30mg/mL Injection by Brooks Pharma Pvt Ltd., KarachiMay 29, 2024
- Introducing Centralized Case Management System for Enhanced Efficiency and TransparencyMay 29, 2024
- Rapid Alert: Drug Product; Falsified Froxime 100mg/5mL Powder for Oral SuspensionMay 28, 2024
- Recall Alert: Drug Product; Zaftolin 5mg/ml Solution by Zafa Pharmaceutical Pvt Ltd, KarachiMay 21, 2024
- Minutes of 335th meeting of Registration Board held on 25th April, 2024May 20, 2024
- Rapid Alert: Contaminated Lot of Sorbitol Identified in KarachiMay 17, 2024
- Recall Alert: Drug Product; Novarise 50mg/5ml Syrup by Sharooq Pharmaceuticals, LahoreMay 16, 2024
- Report on Availability Status and Supply Disruption of Eye DropsMay 13, 2024
- Drug Safety Alert: Risk of Medication Errors resulting Errors resulting due to inadvertent intrathecal Tranexmic Acid InjectionMay 10, 2024
- Drug Safety Alert: Risks associated with the use of Valproic Acid in Women and Girls of Childbearing potential and minor potential risk in male patients.May 10, 2024
- Minutes of 297th Meeting of Central Licensing Board held on 2nd May, 2024May 9, 2024
- Visiting hours of DRAPMay 9, 2024
- Expressions of Interest (EOI) for pool of expert members of central licensing board of DRAPMay 9, 2024
- Drug Safety Alert: Risk of Posterior Reversible Encephalopathy Syndrome (PRES) and Reversible Cerebral Vasoconstriction Syndrome (RCVS) with Pseudoephedrine Containing Medicines.May 7, 2024
- Drug Safety Alert: Risk of Haemophagocytic Lymphohistiocytosis (HLH) with Sulfamethoxazole and Trimethoprim combination.May 7, 2024
- Drug Safety Alert: Risk of Myasthenia Gravis and Ocular Myasthenia with Statins.May 7, 2024
- Schedule of Meetings of Clinical Studies Committee (CSC) for the Year 2024April 30, 2024
- Change in Manufacturing Unit of M/s Sois Life Sciences to Site at G-77. S.I.T.E. Super Highway, Phase-II, Karachi.April 30, 2024
- Minutes of 48th Meeting of Clinical Studies CommitteeApril 30, 2024
- Minutes of 296th Meeting of Central Licensing Board held on 2nd April, 2024April 29, 2024
- Recall Alert; Drug Products: Mebzole 100mg/5mL Suspension and Bioris 1mg/ml Oral Solution by M/s Biolabs Pvt., Ltd., IslamabadApril 29, 2024